Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$160.99 - $215.69 $321 - $431
-2 Reduced 0.65%
305 $58,000
Q1 2023

Apr 13, 2023

BUY
$175.41 - $217.92 $350 - $435
2 Added 0.66%
307 $67,000
Q4 2022

Jan 11, 2023

SELL
$204.38 - $296.82 $204 - $296
-1 Reduced 0.33%
305 $63,000
Q3 2022

Oct 27, 2022

BUY
$195.21 - $310.53 $195 - $310
1 Added 0.33%
306 $85,000
Q2 2022

Jul 12, 2022

SELL
$115.91 - $214.48 $1,854 - $3,431
-16 Reduced 4.98%
305 $58,000
Q1 2022

Apr 27, 2022

SELL
$127.96 - $207.36 $639 - $1,036
-5 Reduced 1.53%
321 $67,000
Q4 2021

Jan 28, 2022

BUY
$165.13 - $241.83 $9,412 - $13,784
57 Added 21.19%
326 $58,000
Q3 2021

Nov 02, 2021

BUY
$163.99 - $235.57 $40,177 - $57,714
245 Added 1020.83%
269 $55,000
Q2 2021

Aug 05, 2021

BUY
$131.45 - $201.49 $3,154 - $4,835
24 New
24 $5,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.